Unified Platform Position ICU Medical's Plum 360 infusion platform as core to IDNs seeking unified infusion therapy across hospitals; emphasize integration with FDA-cleared precision IV pumps and safety software; propose bundle deals with IV sets, connectors, and related accessories to drive standardization.

Respiratory Growth Leverage the VisionHealth collaboration and the MyAcapella Oscillating Positive Expiratory Pressure app to offer a connected respiratory therapy ecosystem, including portable devices, monitoring software, and training packages for chronic patients.

Safety and Compliance Cross-sell closed system transfer devices, needlefree IV connectors, and pharmacy compounding systems to hospital safety initiatives, aligning with regulatory requirements and reducing exposure risks for staff.

Strategic Partnerships Capitalize on AVATAR grant funding and high-profile conference activity to pursue joint R&D with academic and clinical partners, creating pilots and evidence generation to accelerate adoption of ICU Medical products.

Growth and Investment Target large multi-hospital systems and IDNs with multi-product capabilities, leveraging a broad portfolio across infusion, vascular access, respiratory, and monitoring to maximize cross-sell opportunities and expansion into new markets.